Investing.com - Financial Markets Worldwide

BioLight Life Sciences Ltd (BOLT)

Tel Aviv
Currency in ILS
529.3
0.0(0.00%)
Delayed Data·
BOLT Scorecard
Full Analysis
Holds more cash than debt on its balance sheet
BOLT is not included in our AI-picked strategies. See which stocks are.
Fair Value
Unlock Value
Day's Range
529.3529.3
52 wk Range
396.0702.0
Key Statistics
Edit
Bid/Ask
510.20 / 530.00
Prev. Close
529.3
Open
529.3
Day's Range
529.3-529.3
52 wk Range
396-702
Volume
-
Average Volume (3m)
4.26K
1-Year Change
35.75%
Fair Value
unlockUnlock
Fair Value Upside
unlockUnlock
BOLT Scorecardpro icon
Company’s Health
Unlock
Fair Value
Unlock Price
Fair Price
Upside
Technical Analysis
Sell
Analysts Sentiment
Currently not supported.
Members' Sentiments
Bearish
Bullish
ProTips
Unlock All 7
Quickly burning through cash
Unlock InvestingPro

Technical Analysis

Summary
Strong Sell
Sell
Neutral
Buy
Strong Buy
Strong Buy
Technical Indicators
Strong Buy
Moving Averages
Buy

BioLight Life Sciences Ltd Company Profile

BioLight Life Sciences Ltd., an ophthalmic company, engages in the discovery, development, and commercialization of products and product candidates that address ophthalmic conditions. The company’s ophthalmic product offering and pipeline of product candidates include DiagnosTear’s TeaRx technology, a diagnostic platform for diagnosis of disease in the frontal areas of the eye through examination of a number of substances in the composition of teardrops; ViSci, an Eye D technology that treats glaucoma by the insertion of a sub conjunctival implant; OphRx that develops drugs for treating eye diseases; and Peripherex, which develops solutions for at-home and in-office diagnosis and monitoring of peripheral vision impairment used by eye care and other providers to diagnose and monitor glaucoma and other diseases. Its pipeline also include AEYE that develops artificial intelligence solutions for a variety of retinal diseases; Tarsier, which develops TRS 01 based on its technological platform for the treatment of Uveitis in patients suffering from high IPO; Belkin Vision that develops clinic fast and automatic laser device to enable glaucoma patients to receive short & effective treatments as treatment to lower IOP; and Sanoculis, which develops an innovative surgical procedure for the treatment of the Glaucoma. The company was formerly known as Bio Light Israeli Life Sciences Investments Ltd. and changed its name to BioLight Life Sciences Ltd. in February 2016. BioLight Life Sciences Ltd. was incorporated in 2005 and is based in Tel Aviv, Israel.

Industry
Healthcare Equipment & Supplies
Sector
Healthcare
Employees
4
Market
Israel

Compare BOLT to Peers and Sector

Metrics to compare
BOLT
Peers
Sector
Relationship
P/E Ratio
−2.0x−3.0x−0.6x
PEG Ratio
−0.050.000.00
Price/Book
1.0x1.2x2.6x
Price / LTM Sales
146.9x1.7x3.3x
Upside (Analyst Target)
-157.3%40.2%
Fair Value Upside
Unlock5.8%5.1%Unlock

Earnings

Latest Release
May 26, 2025
EPS / Forecast
-0.52 / --
Revenue / Forecast
-- / --
EPS Revisions
a
a
Unlock
Last 90 days

BOLT Income Statement

FAQ

What Stock Exchange Does Bio Light Trade On?

Bio Light is listed and trades on the Tel Aviv Stock Exchange stock exchange.

What Is the Stock Symbol for Bio Light?

The stock symbol for Bio Light is "BOLT."

What Is the Bio Light Market Cap?

As of today, Bio Light market cap is 24.82M.

What Is Bio Light's Earnings Per Share (TTM)?

The Bio Light EPS (TTM) is -2.73.

From a Technical Analysis Perspective, Is BOLT a Buy or Sell?

Based on moving averages and other technical indicators, the daily buy/sell signal is Sell.

How Many Times Has Bio Light Stock Split?

Bio Light has split 4 times.

How Many Employees Does Bio Light Have?

Bio Light has 4 employees.

What is the current trading status of Bio Light (BOLT)?

As of 18 Aug 2025, Bio Light (BOLT) is trading at a price of 529.30, with a previous close of 529.30. The stock has fluctuated within a day range of 529.30 to 529.30, while its 52-week range spans from 396.00 to 702.00.
Install Our App
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers
© 2007-2025 - Fusion Media Limited. All Rights Reserved.